Thrombospondin-1 Serum Levels In Hypertensive Patients With Endothelial Dysfunction After One Year Of Treatment With Perindopril
Valentina Buda,1,* Minodora Andor,2,* Carmen Cristescu,1,* Mirela Cleopatra Tomescu,2 Danina M Muntean,3 Dana Emilia Bâibâță,4,5 Diana Aurora Bordejevic,4,5 Corina Danciu,6 Olivia Dalleur,7 Dorina Coricovac,8 Zorin Crainiceanu,9 Anca Tudor,10 Ionut Ledeti,11 Lucian Petrescu4,5 1D...
Main Authors: | Buda V, Andor M, Cristescu C, Tomescu MC, Muntean DM, Bâibâță DE, Bordejevic DA, Danciu C, Dalleur O, Coricovac D, Crainiceanu Z, Tudor A, Ledeti I, Petrescu L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/thrombospondin-1-serum-levels-in-hypertensive-patients-with-endothelia-peer-reviewed-article-DDDT |
Similar Items
-
Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment
by: Valentina Buda, et al.
Published: (2017-02-01) -
Decreased sEng plasma levels in hypertensive patients with endothelial dysfunction under chronic treatment with Perindopril
by: Buda V, et al.
Published: (2019-06-01) -
Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation
by: Valentina Buda, et al.
Published: (2017-01-01) -
TGF-β promotes microtube formation in glioblastoma through thrombospondin 1
by: Berven, F.S, et al.
Published: (2022) -
Increased cardiovascular mortality in females with the a/a genotype of the SNPs rs1478604 and rs2228262 of thrombospondin-1
by: Urban Alehagen, et al.
Published: (2020-09-01)